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TREATMENT OF THE TYPHOID CARRIER STATE WITH
CHLORAMPHENICOL*
THOMAS TIMOTHY CROCKERt AND ABRAHAM GELPERIN
The efficacy of chloramphenicol: in the treatment of acute typhoid fever
is well established.84' 9l0'1 18 However, treatment of the typhoid carrier state
with this antibiotic, for varying periods of time and at dosage levels
generally accepted as high, has been unsatisfactory.2 Untoward reactions
have also been reported,'2,6 of which anorexia, nausea, and a bitter taste
in the mouth were the most frequent manifestations, although occasionally
glossitis and cheilosis occurred in persons under prolonged treatment with
large doses of the antibiotic. This communication presents the results of a
quantitative study of the carrier state and the influence of chloramphenicol
upon it in two chronic typhoid carriers. In addition, a description of the
development and treatment of untoward oral manifestations similar to those
previously described is included.
Both subjects of this investigation had a history of acute typhoid fever
(patient E. G., 24 years before, and patient R. L., 48 years before this
study) and both had been known typhoid carriers for eight years. The
following are pertinent data concerning these patients:
E. G., female, age 48 years, weight 257 pounds, gave a history of prolonged
intolerance to fatty and fried foods and mild chronic epigastric distress and flatulence,
suggestive of chronic cholecystitis. There were no episodes of jaundice, biliary colic,
or acute cholecystitis. The patient's diet was interpreted as substandard with respect to
animal protein and vitamin B content.
R. L., female, age 72 years, weight 183 pounds, had moderately severe cardiovascular
disease of uncertain duration and was under clinic care. There was no history sug-
gestive of biliary tract disease. The patient's diet was interpreted as barely adequate
with respect to animal protein and vitamin B content.
Careful initial physical examination of both patients showed no evidence of vitamin
deficiency. Repeated urine cultures were negative for S. typhosa. The gallbladder
could not be visualized with radio-opaque medium in either patient; cholelithiasis was
not evident on x-ray examination.
Methods and materials
Preliminary to chloramphenicol therapy the feces of both patients were examined
bacteriologically once weekly for 14 weeks in an effort to determine quantitative
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variations in excretion of S. typhosa.* This examination continued at weekly intervals
for one month during and after treatment to ascertain the extent and duration of any
suppression of typhoid organisms which might result.
Samples of bile obtained by duodenal intubation before and during chloramphenicol
therapy were also examined bacteriologically. At each intubation 5 to 20 ml. volumes
of duodenal contents were aspirated at 5-, 15-, and 25-minute intervals after delivery
into the duodenum of 60 ml. of a 50 per cent magnesium sulfate solution. All samples
were examined bacteriologically and were assayed for the presence of active
chloramphenicol.
Counts of S. typhosa in fresh stool and bile were determined by inoculating liquid
Difco bismuth sulfite with 10-fold dilutions of feces or bile. Each dilution was
delivered in 4.5 ml. quantities into each of two petri dishes, and 20 ml. of liquid
bismuth sulfite agar were then added and mixed well by swirling. The black
Salmonella colonies were counted after incubation for 48 hours at 37° C., and the
highest dilution of inoculum which produced one to thirty colonies was recorded as
the end point. Colonies from these end-point plates were identified periodically by
phage typing, cultural studies, and slide agglutination tests.
Sensitivity of the S. typhosa strains isolated from these patients was determined
with respect to chloramphenicol by two techniques. In one, an 18-hour broth culture
of the organism was streaked on plates of nutrient agar containing 1.56, 2.56, 3.12,
12.5, and 25.0 micrograms/ml. of crystalline chloramphenicol. In the second technique,
an 18-hour broth culture of freshly isolated S. typhosa was diluted to 10-8 and added
in 1.5 ml. portions to tubes containing varying concentrations of crystalline antibiotic
in 0.5 ml. of broth, so that the final concentrations of chloramphenicol were 1.87, 2.33,
3.12, 4.67, 6.25, 9.4, and 12.5 micrograms/ml. The lowest concentration of antibiotic
at which no growth was visible after incubation for 24 hours at 370 C. was recorded
as the level of sensitivity of the organism by the method employed.
The quantity of chloramphenicol in serum, bile, and urine was determined
periodically during treatment. A modificationt of the method of Joslyn and
Galbraith7"1 was employed, in which an 18-hour broth culture of S. sonnei diluted
to 1.5 by 10-8 in broth was added in 1.5 ml. volumes to samples of body fluids which
had been diluted serially in broth and transferred to the culture tubes in 0.5 ml.
quantities. Inhibition of growth of the test organism by the body fluids was determined
visually after incubation for 18 hours at 300 C. Identical inocula of the diluted
S. soninei culture were added to a series of tubes containing 0.5 ml. volumes of
crystalline chloramphenicol in broth in quantities such that the final concentrations
of the antibiotic were 0.233, 0.312, 0.467, 0.625, 0.940, and 1.25 micrograms/ml. The
quantity of chloramphenicol in each sample of body fluid was then determined by
multiplying the lowest dilution of the sample that caused complete inhibition of
S. sonnei by the number of micrograms per milliliter of chloramphenicol in the first
tube of the standard series in which complete inhibition was observed. All dilutions
of body fluids were prepared in duplicate, and as many samples as possible were
examined in a single test. On a few occasions the same sample of body fluid was
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examined on two or more separate test days. No significant variation was noted among
results of several tests on a single sample, nor between duplicate samples in a single
test. Samples of urine and bile were filtered through Seitz pads or sintered glass if
preliminary culture proved them to be contaminated. All samples were stored at
-20° C. soon after being obtained from the patients.
Chloramphenicol was administered in gelatin capsules in a total daily
dose of 3.75 grams, given on a schedule of 0.75 gram every four hours for
five doses, in a program of self-administration. Treatment continued for
15 days (R.L.) and 19 days (E.G.), with certain departures from the
original dosage schedule required by the appearance of untoward reactions,
presumably due to the antibiotic. Thus, patient E.G. followed the 3.75 gram
per day schedule with one 30-hour lapse during the sixth and seventh days
of treatment; and patient R. L. adhered to the initial schedule until the
tenth day, at which time the dosage was reduced to 2.25 grams a day. In




; ° ~~~~~~~~~~~~~~~~~~~Ti ter
3 L ~~~~~~~~~~~~~~~~~~R *L*
CW 10 TRE:^fNT
X ,PE:RIOD
POSt1P f O O Negative
6 16 26 a 18 28 7 1.7 27 7 17 27 6 16 28 6
ARr MARCR APRIL KLY JI0 t
0 RL4TStool Cul O R -L.*, all cultUr -_ .L, Stool Culture 0D a Not DoR 0 .ZG, Ble Cualtur
FIG. 1. Results of quantitative determinations of S. typhosa in samples of feces and
bile obtained from two typhoid carriers before, during, and after chloramphenicol
therapy.
grams a day from the twelfth to the fifteenth day of treatment. Even with
the reduced dosage, the schedule of five daily doses at 4-hour intervals was
retained. In terms of body weight these dosages represented 33 mg./kg./day
for 19 days (E.G.); and 44 mg./kg./day for 9 days, 26 mg./kg./day for
2 days, and 23 mg./kg./day for 4 days (R.L.).
Results
Salmonella typhosa, Vi form, bacteriophage types E1 (patient E.G.) and
F2 (patient R.L.), were consistently isolated from fecal and bile samples.
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The concentrations of typhoid bacilli in fecal samples, summarized in
Figure 1, were generally high and fluctuated over a ten-fold range (R.L.)
or a hundred-fold range (E.G.) during the pretreatment study of each
patient. An exception is evident in the first stool sample from E. G., which
was negative, probably through technical error.
During chloramphenicol administration, the S. typhosa counts in stool
specimens from R. L. on one occasion dropped one thousand-fold below the
counts observed during the immediate pretreatment period. Only a ten-
fold decrease in numbers of S. typhosa was observed in bile obtained during
treatment. Excretion of S. typhosa in the stools of this patient returned to
pretreatment levels immediately after cessation of therapy.
TABLE 1
CHLORAMPHENICOL LEVELS IN SERUM, URINE, AND BILE DURING TREATMENT OF
Two TYPHOID CARRIERS
Day of Hourssince Chloramphenicol level, gamma/ml.
Patient treatment last dose Serum Urine Bile
O No drug 0 0 0
2 8 1.87 74.7
E.G. 15 5 7.50 37.6 0 to 2.5
16 2Y4 11.28
19 2}4 3.76
0 No drug 1.87* 0 0
R.L. 2 8 7.47 74.7
15 4 0
* Minimal but definite inhibition of growth of the test organism was consistently
produced by this serum sample although no antibiotic had been administered.
The concentration of typhoid bacilli observed in the feces of patient E. G.
during antibiotic administration was depressed briefly only ten-fold below
the lowest pretreatment level. One sample of bile showed considerable
numbers of organisms during the treatment period.
Serum and urine levels of chloramphenicol were, in general, at the lower
limit of the range to be expected from the dosage used in this trial (Table
1). The antibiotic was present in amounts varying from 1.87 to 7.4 micro-
grams/ml. in serum obtained 8 hours after completion of one day of
treatment. This should represent the lowest serum level occurring in any
24-hour period during treatment. Chloramphenicol content of bile varied
from none to 2.5 micrograms/ml. in patient E. G., and was zero in patient
R. L. All specimens of bile obtained at each intubation were tested.
Sensitivity of the S. typhosa strains studied in this trial varied according
to the technique employed. On agar plates containing chloramphenicol the
limit of sensitivity was 3.12 micrograms/ml.; in broth tubes containing
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chloramphenicol it was 1.87 micrograms/ml. No alteration in sensitivity
of either strain of S. typhosa was observed by these methods before, during,
or after therapy.
Untoward oral reaction. Intense pain and swelling of the oral mucous
membranes, with dysphagia, rawness, burning of the tongue, and bitter
tasting saliva, accompanied by anorexia, occurred in both patients during
chloramphenicol administration. The symptoms of these reactions were first
noted on the fifth day (E.G.) and the seventh day (R.L.) of therapy. In
both patients the tongue was beefy red, with smooth lateral borders and
hypertrophied papillae. Examination also revealed edema and marked red-
dening of the soft palate and buccal and pharyngeal mucosae. Both patients
developed cheilosis of one corner of the mouth soon after the first signs
appeared. Mucosal ulcerations or exudate were absent and the gums were
not involved. Neither patient demonstrated skin lesions, tendon reflex
changes, alterations in number or character of red or white blood cells,
urinary abnormalities, or diarrhea. In patient E. G. there was an initial
low fever, cervical adenopathy, and elevation of the white blood cell count.
No pathogens were found in bacteriological cultures of scrapings from this
patient's oral and pharyngeal mucosa, but numerous fusospirochaetal organ-
isms were discovered on microscopic examination of a stained smear.
Penicillin, 300,000 units a day for two days, administered parenterally,
effected prompt relief of fever, cervical adenitis, and pharyngeal soreness,
but did not alter the red, painful lingual and buccal mucosal reaction.
Niacinamide, given orally in 100 mg. daily doses for three days (E.G.),
or concentrated B complex vitamins, given parenterally and orally for four
days (R.L.), were administered while antibiotic treatment continued. All
symptoms, except the bitter taste of the saliva, were relieved in both
patients within 24 hours, and objective findings were markedly reduced in
48 hours. The clinical signs disappeared completely by the fourth to fifth
day after vitamin administration was begun, although chloramphenicol
therapy was continued.
Summary and conclusions
Two chronic typhoid carriers showed high, nearly constant levels of
excretion of phage types E1 or F2 of S. typhosa during 14 weekly examina-
tions of feces prior to treatment with chloramphenicol. The bile of both
carriers, obtained by duodenal intubation, contained large numbers of
typhoid bacilli on at least one occasion.
Chloramphenicol was administered in dosages of from 22 to 44
mg./kg./day for 15 or 19 days. The quantities of antibiotic in serum and
urine were sufficient to suggest adequate absorption from the intestine, but
little or no active chloramphenicol was detected in samples of bile obtained
by duodenal intubation.
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It is not certain whether high biliary excretion of chloramphenicol is
required for successful treatment of the biliary typhoid carrier state.
Woodward et al.,' in studies of concentration of chloramphenicol in bile,
found levels approximately one-half as great as the levels detected in
samples of serum obtained simultaneously. In patients with normally func-
tioning gallbladders these levels should exceed the limit of sensitivity of the
organisms carried by the subjects in this study. Both patients presented
here showed evidence of gallbladder disease, so that if high concentrations
of chloramphenicol in bile are necessary, these patients may have been at a
disadvantage because of their reduced capacity to concentrate hepatic bile.
It would seem, further, that if continued studies of the quantity of chloram-
phenicol in the bile are pertinent, it would be more profitable to obtain
samples of bile directly from the biliary system rather than by duodenal
intubation.
Only slight suppression of the fecal excretion of S. typhosa was noted
during treatment with chloramphenicol, and the large quantities of typhoid
bacilli observed originally were found in the feces immediately after cessa-
tion of therapy. This confirms the observations of other investigators who
report little effect by chloramphenicol upon the typhoid carrier state.
An untoward oral reaction, resembling that caused by vitamin B
deficiency, appeared in one patient within five days, and in the other within
seven days after initiation of oral administration of chloramphenicol.
Reduction of dosage for one patient did not influence the reaction. When
niacinamide or a multiple B vitamin preparation was administered, prompt
improvement of the oral reaction occurred while chloramphenicol admin-
istration was continued. Similar amelioration of these side effects of
chloramphenicol have been reported by Harris. Although neither patient
had shown clinical evidence of vitamin B deficiency before treatment, the
diet of one patient had been insufficient in vitamins of the B group, and
the diet of the other had been marginal in this regard. It is possible
that their dietary backgrounds contributed to the untoward reactions
experienced by these patients.
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